Clinical Trials Logo

Obesity clinical trials

View clinical trials related to Obesity.

Filter by:

NCT ID: NCT02872740 Not yet recruiting - Obesity Clinical Trials

Gastric Arterial Embolization for Weight Loss

Start date: August 2016
Phase: N/A
Study type: Interventional

Title: Embolization of Gastric Arterial Supply for Weight Loss Sample size: 10 patients Study Population: Morbidly obese patients who were seen by the bariatric surgery program at Toronto Western Hospital but are either not interested or not eligible for surgery. Study Design: Single center, randomized, prospective, non-blinded pilot study. Study Duration: 12 months (November 2015 - December 2015). Agent: 150-250 micron polyvinyl alcohol particles Primary objective: To further evaluate the safety of embolization of the left gastric and gastroepiploic arteries. To determine if either or both will result in significant weight loss and decrease in waist circumference among obese patients. Primary objective measure: The number of adverse events in a 1 year period will be recorded. The weight change from baseline will be recorded.

NCT ID: NCT02872493 Recruiting - Obesity Clinical Trials

Small Bowel Length and Bariatric Surgery Outcomes

Start date: August 2016
Phase: N/A
Study type: Observational

The purpose of this study is to determine whether or not the total length of small intestine effects outcomes after bariatric surgery in a cohort of patients preoperatively and up to ten years postoperatively. Roux-en-Y gastric bypass and vertical sleeve gastrectomy will be the surgical groups in this study. We aim to determine if bowel length has a significant effect on long term weight loss or other nutritional deficiencies in this bariatric cohort.

NCT ID: NCT02870322 Recruiting - Obesity Clinical Trials

Fruit And Vegetable Or Recreation Prescriptions for UW-Madison Students

FAVORx
Start date: July 2016
Phase: N/A
Study type: Interventional

This research will use randomized controlled trial (RCT) methodology to assess the feasibility of a prescription for fruit/vegetable CSA shares or exercise by bikeshare on obesity-related outcomes. Three cohorts of n=10 University of Wisconsin-Madison (UW) students (total 30) will be randomized to three groups: (1) a 10-week fruit and vegetable community supported agriculture (CSA) share prescription program with vegetable education and cooking support from UW Slow Food; (2) a 10-week Madison B-cycle bikeshare membership prescription program with exercise support or (3) a non-interventional wait-list control group. The primary outcome will be change in Body Mass Index (BMI) (a measure of obesity using a person's weight in kilograms divided by his or her height in meters squared). Secondary outcomes will be fasting lipids, blood pressure, and glycated hemoglobin (HGA1c) levels. All of these measures will be tested at baseline and just after the 10-week intervention

NCT ID: NCT02870231 Recruiting - Obesity Clinical Trials

A Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity

Start date: August 2016
Phase: Phase 1
Study type: Interventional

This trial is conducted in the United States of America. The aim of this trial is to investigate Safety, Tolerability, PK (the exposure of the trial drug in the body) and PD (the effect of the investigated drug on the body) for Multiple Doses of NNC9204-0530 in Combination with Liraglutide in Male and Female Subjects being Overweight or with Obesity

NCT ID: NCT02869659 Not yet recruiting - Obesity Clinical Trials

Valued EpiGenetic Glycemic ImprovEments Through Weight Loss

VEGGIE
Start date: September 2016
Phase: N/A
Study type: Interventional

This randomized controlled clinical trial will use methylomic and transcriptomic profiling to examine the effects of a weight loss intervention on the cholesterol metabolism gene network in monocytes and adipocytes and investigate the longitudinal relationship between these modifications and glycemic improvements.

NCT ID: NCT02868905 Not yet recruiting - Obesity Clinical Trials

Identification of Epigenetic Markers Common to Obesity and Alzheimer's Disease in Women

Oba
Start date: September 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to compare average methylation of epigenetic markers on genomic DNA and some genes (APP, BACE, LRP, SorL1) involved in cerebral amyloid homeostasis: - Of obese young adults and healthy young adults - Of obese young adults and individuals affected by Alzheimer's disease (AD) having been obese at young adult age (<50 years old) or individuals affected by Alzheimer's disease (AD) having never been obese. The secondary purpose is to determine if there is an association between the frequency of these epigenetic markers and elements associated to the metabolic syndrome (lipidic and glycemic analysis, leptinemia, inflammation markers) and clinical ones (visceral fat mass, body mass index) in young adults.

NCT ID: NCT02868853 Recruiting - Obesity Clinical Trials

Self-Monitoring Assessment in Real Time

2-SMART
Start date: August 2016
Phase: Phase 1
Study type: Interventional

The purpose of the study is to test the effectiveness of two different methods of mobile dietary self-monitoring for weight loss. Both of these interventions will provide weight loss information through twice weekly audio podcasts. In addition to the podcasts, participants will be asked to track their diet using an assigned mobile applications (for their smartphone), which will be randomly assigned.

NCT ID: NCT02868619 Recruiting - Obesity Clinical Trials

Binge Eating Disorder and Obesity : Functional MRI Study

BED
Start date: September 2014
Phase: N/A
Study type: Interventional

Obesity, defined as BMI> 30kg / m2, is a major public health problem, with devastating medical and psychological consequences. 30% of obese suffer from BED type of eating disorders. The optimal treatment of obesity remains bariatric surgery, failed in 20% of cases. Many arguments are in favor of the involvement of the reward circuitry, with the central role of NAc in the pathophysiology of BED and obesity. The recent application and effectiveness of DBS (Deep Brain Stimulation) in refractory psychiatric disorders suggest that DBS may be of interest in treating obesity and BED with potential target for the NAc. This project propose to study fMRI activation of the reward system in response to food stimuli to better direct the DBS targets. This is a pilot study to define indication criteria based on fMRI to obese BED patients are potential candidates for treatment with DBS.

NCT ID: NCT02868489 Not yet recruiting - Obesity Clinical Trials

Effect of Bacillus Coagulans and Galactomannans on Microbiota in Obese Patients Undergoing Sleeve Gastrectomy

Start date: September 2016
Phase: N/A
Study type: Interventional

The hypothesis is to determine the effect of bacillus coagulans and galactomannans (LactoWise®) administration on microbiota of obese patients undergoing sleeve gastrectomy by observing standard protocol measurements in patients following sleeve gastrectomy: blood markers and weight, in addition incorporating the Gastrointestinal Quality of Life Index (GIQLI)

NCT ID: NCT02868177 Recruiting - Obesity Clinical Trials

Effect of Valedia on Glucose and Lipid Homeostasis on Subjects With Prediabetes

VALEDIA-ONE
Start date: January 2016
Phase: Phase 2/Phase 3
Study type: Interventional

Given the data on the active ingredients of Valedia, this research aims to evaluate the effect of its chronic consumption (24 weeks) in association with some vitamins and trace elements on glucose and lipid homeostasis and especially on fasting plasma glucose in volunteers with abdominal obesity associated with impaired glucose tolerance or untreated type 2 diabetes and hypertriglyceridemia. This clinical study is designed as a pilot study in order to estimate the effect of a dietary supplement formula containing Valedia, vitamins and trace elements and its variance on several glucose and lipid homeostasis related parameters since these data are still unknown for this specific dietary supplement formula. Collected data will provide more reliable information which may be used to plan a subsequent larger main study.